R. Russell (Lymington (Hampshire), United Kingdom), C. Sorino (Fino Mornasco (CO), Italy)
Late Breaking Abstract - Nationwide asthma management and disease control in primary versus secondary care – a real-world evidence study
K. Håkansson (Hvidovre, Denmark), V. Backer (Copenhagen, Denmark), C. Ulrik (Hvidovre, Denmark)
|   |
Numerical simulation of the effect of inhalation parameters and disease severity on the deposition of dry powder aerosol drugs in COPD patients
A. Farkas (Budapest, Hungary), A. Horváth (Budapest, Hungary), G. Tomisa (Budapest, Hungary), G. Gálffy (Törökbálint, Hungary), J. Varga (Budapest, Hungary)
| |
Developing evidence-based recommendations regarding inhalation technique in patients with COPD
L. Jørgensen (Aarhus, Denmark), K. King (Aarhus, Denmark), N. Lyhne (Aarhus, Denmark), A. Loekke (Aarhus, Denmark)
| |
How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis
J. Suggett (London (ON), Canada), V. Kushnarev (London (ON), Canada), D. Coppolo (NY, United States of America), J. Tse (Virginia, United States of America), K. Wada (Virginia, United States of America)
| |
Effectiveness of an educational intervention in order to improve adherence in COPD and asthma ambulatory patients.
J. Alcantara Fructuoso (Murcia, Spain), J. Sánchez Nieto (Murcia, Spain), I. Fernández Muñoz (Murcia, Spain), M. Garci-Valera Orea (Murcia, Spain), J. Vera Olmos (Murcia, Spain), J. Fernández Álvarez (Murcia, Spain)
| |
COPD exacerbations and adherence to treatment improvement:what goal can be achieved?
A. Sidorov (Vinnitsa, Ukraine), Y. Mostovoy (Vinnitsa, Ukraine), N. Slepchenko (Vinnitsa, Ukraine), N. Tsymbaliuk (Vinnitsa, Ukraine), K. Dmytriiev (Vinnitsa, Ukraine)
| |
Spirometry parameters and adherence to COPD treatment: is there association?
A. Sidorov (Vinnitsa, Ukraine), Y. Mostovoy (Vinnitsa, Ukraine), N. Slepchenko (Vinnitsa, Ukraine), N. Tsymbaliuk (Vinnitsa, Ukraine), K. Dmytriiev (Vinnitsa, Ukraine)
| |
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study
I. Baiardini (Milano (MI), Italy), P. Rogliani (Roma, Italy), P. Santus (Milan, Italy), M. Contoli (Ferrara, Italy), C. Scognamillo (Milano (MI), Italy), A. Corsico (Pavia, Italy), N. Scichilone (Palermo, Italy), F. Ferri (Modena, Italy), F. Di Marco (Bergamo, Italy), F. Braido (genova, Italy)
| |
Investigating the percentage of patients with COPD who could benefit from a change in inhaler
K. King (Århus N, Denmark), L. Jørgensen (Århus N, Denmark), N. Lyhne (Århus N, Denmark), A. Løkke (Århus N, Denmark)
| |
Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI).
G. Crater (South San Francisco, United States of America), E. Moran (South San Francisco, United States of America), J. Ward (Sandwich, United Kingdom), D. Belmans (Antwerp, Belgium), C. Van Holsbeke (Antwerp, Belgium)
| |
Exercise capacity and dyspnea challenge of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN)
C. Nickerson (Murrysville, United States of America), D. Von Hollen (Murrysville, United States of America), S. Garbin (Murrysville, United States of America), K. Doty (Murrysville, United States of America), J. Jasko (Murrysville, United States of America), C. Cain (Murrysville, United States of America)
| |
Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
I. Markou (Pikermi, Greece), S. Tryfon (Thessaloniki, Greece), E. Tsikrika (Veroia, Greece), G. Krommidas (Athens, Greece), D. Lekkos (Ioannina, Greece), A. Athanassiou (Pikermi, Greece)
| |
Preference and quality of life of adult chronic obstructive lung disease (COPD) patients when using a novel mesh nebulizer compared to traditional jet nebulizer (TJN)
C. Nickerson (Murrysville, United States of America), D. Von Hollen (Murrysville, United States of America), S. Garbin (Murrysville, United States of America), K. Doty (Murrysville, United States of America), J. Jasko (Murrysville, United States of America), C. Cain (Murrysville, United States of America)
| |
NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS
P. Imitazione (Napoli, Italy), M. Lanza (Napoli, Italy), R. Cobuccio (Napoli, Italy), S. Musella (Napoli, Italy), R. Cauteruccio (Napoli, Italy), A. Annunziata (Napoli, Italy), G. Fiorentino (Napoli, Italy)
| |
Four years of targeted education are fundametally changing the inhalation technique
V. Koblizek (Hradec Králové, Czech Republic), M. Kopecky (Hradec Králové, Czech Republic), L. Nevoranek (Hradec Králové, Czech Republic), T. Hendrychova (Hradec Králové, Czech Republic), J. Vlcek (Hradec Králové, Czech Republic)
| |
Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model
M. Nagel (London (ON), Canada), J. Suggett (London (ON), Canada), A. Ellery (London (ON), Canada)
| |
Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD
E. Björk (Stockholm, Sweden), P. Thind (Stockholm, Sweden), M. Qvarfordt (Uppsala, Sweden), M. Svartengren (Uppsala, Sweden), M. Anderson (Stockholm, Sweden)
| |
Feasibility, compliance and effects of a Mindfulness program on COPD patients
S. Bensliman (Brussels, Belgium), V. Ninane (Brussels, Belgium), C. Mélot (Brussels, Belgium)
| |
Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD
F. Grewe (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), M. Bradicich (Zurich, Switzerland), M. Roeder (Zurich, Switzerland), T. Brack (Glarus, Switzerland), M. Brutsche (St. Gallen, Switzerland), M. Frey (Barmelweid, Switzerland), S. Irani (Aarau, Switzerland), J. Leuppi (Basel, Switzerland), R. Turnheer (Münsterlingen, Switzerland), C. Clarenbach (Zurich, Switzerland), M. Kohler (Zurich, Switzerland)
| |